Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study

Bone Marrow Transplantation
I EstevesN Hamerschlak

Abstract

Patients with refractory severe aplastic anemia (SAA) who lack a matched sibling or unrelated donor need new therapeutic approaches. Hematopoietic SCT (HSCT) using mismatched or haploidentical related donors has been used in the past, but was associated with a significant risk of GVHD and mortality. Recently, the use of post-transplant cyclophosphamide (Cy) has been shown to be an effective strategy to prevent GVHD in recipients of haploidentical HSCT, but the majority of reports have focused on patients with hematology malignancies. We describe the outcome of 16 patients who underwent haploidentical transplantation using a reduced-intensity conditioning regimen with post-transplant Cy. Stem cell sources were BM (N=13) or PBSCs (N=3). The rate of neutrophil engraftment was 94% and of platelet engraftment was 75%. Two patients had secondary graft failure and were successfully salvaged with another transplant. Three patients developed acute GVHD being grades 2-4 in two. Five patients have died and the 1-year OS was 67.1% (95% confidence interval: 36.5-86.4%). In our small series, the use of a reduced-intensity conditioning with post-transplant Cy in haploidentical BMT was associated with high rates of engraftment and low risk of ...Continue Reading

References

Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Nov 15, 2002·International Journal of Hematology·Seiji Kojima
Apr 23, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J F LacerdaJ M F Lacerda
Dec 29, 2007·American Journal of Hematology·Tatsuya ChuhjoShinji Nakao
May 21, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Leo LuznikEphraim J Fuchs
Sep 15, 2010·Bone Marrow Transplantation·A E DezernR A Brodsky
Dec 14, 2011·Hematology·Manuel G AfableJaroslaw P Maciejewski
Feb 9, 2012·Haematologica·Andrea BacigalupoUNKNOWN Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (WPSAA-EBMT)
Apr 21, 2012·Blood·Phillip Scheinberg, Neal S Young
May 1, 2012·Blood·Judith C MarshUNKNOWN European Blood and Marrow Transplant Group Severe Aplastic Anaemia Working Party
Jul 6, 2012·The New England Journal of Medicine·Matthew J OlnesCynthia E Dunbar
Jul 17, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stefan O CiureaRichard E Champlin
Jan 8, 2013·Bone Marrow Transplantation·R Peffault de LatourG Socié
Jan 8, 2013·Bone Marrow Transplantation·F CiceriE T Korthof
Sep 21, 2013·Blood·Judith C W Marsh, Austin G Kulasekararaj
Nov 15, 2013·Science Translational Medicine·Christopher G KanakryLeo Luznik
Jan 15, 2014·American Journal of Hematology·Phillip ScheinbergNeal S Young
Mar 22, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kavita RajPaul O'Donnell
Jul 13, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jennifer ClayJudith C W Marsh

❮ Previous
Next ❯

Citations

Mar 24, 2016·Seminars in Hematology·Andrea Bacigalupo, Simona Sica
Dec 3, 2015·Current Opinion in Pediatrics·Andrew C DietzMichael A Pulsipher
Apr 14, 2016·Journal of Hematology & Oncology·Ying-Jun ChangXiao-Jun Huang
Jun 29, 2016·British Journal of Haematology·Lan-Ping XuXiao-Jun Huang
Jul 13, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yachiyo KuwatsukaUNKNOWN Japan Society for Hematopoietic Cell Transplantation
Oct 18, 2016·Current Opinion in Hematology·George E Georges, Rainer Storb
Nov 12, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Carmem BonfimRicardo Pasquini
Dec 17, 2016·Revista da Associação Médica Brasileira·Nelson Hamerschlak
Apr 12, 2017·Expert Review of Hematology·Alberto MussettiPaolo Corradini
Jan 18, 2017·Blood·Andrea Bacigalupo
Jan 25, 2017·Current Hematologic Malignancy Reports·Alice BertainaMattia Algeri
Jul 12, 2017·Bone Marrow Transplantation·L S BachegowdaS O Ciurea
Mar 2, 2018·Expert Review of Hematology·Yu-Qian SunXiao-Jun Huang
Dec 7, 2018·Hematology·Andrea Bacigalupo
Jul 18, 2019·Expert Review of Hematology·Filomena Pierri, Carlo Dufour
Sep 7, 2017·Current Opinion in Hematology·Rajat KumarBiju George
Jul 4, 2020·Journal of Paediatrics and Child Health·Eliska Furlong, Tina Carter
Oct 26, 2018·The New England Journal of Medicine·Neal S Young
Feb 8, 2019·Bone Marrow Transplantation·Jakob R PasswegUNKNOWN European Society for Blood and Marrow Transplantation (EBMT)
Oct 3, 2018·Case Reports in Medicine·Hafiz Muhammad AslamShahrukh K Hashmi
Jul 2, 2018·Current Oncology Reports·Nao Yoshida, Seiji Kojima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.